openPR Logo
Press release

Pulmonary Needles Market Projected to Augment at a Notable CAGR during the Forecast Period until 2028(Based on clinical indications, the global pulmonary needles market is divided into the following: Tumor Malignancy Non-Malignant Infectious Diseases Card

05-17-2019 09:27 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Pulmonary Needles Market Projected to Augment at a Notable CAGR

A pulmonary needle is a hollow hypodermic needle designed for insertion into the lungs. Pulmonary needles are used for diagnosis, prognosis or treatment of lung disorders, such as cancer, and infective diseases, such as tuberculosis, abscess, sepsis, viral and bacterial infection and others. Biopsy and aspiration are the major procedures that account for the major use of pulmonary needles. Manual loading is being increasingly replaced by automatic, spring-loaded mechanisms or vacuum-assisted devices (VADs).

Pulmonary Needles Market: Drivers and Restraints

Increase in the number of various procedures, such as fine needle aspiration and biopsies, owing to the growing prevalence of lung diseases, such as infections, bronchitis and cancer, due to growing risk factors, such as smoking, exposure to allergens and carcinogens and others, is the prime driver for the pulmonary needles market. The American Cancer Society’s estimates about 234,030 new cases of lung cancer and about 154,050 deaths in 2018.

The primary technological driver for the pulmonary needles market is the rapid adoption of diagnostics, such as computed tomography (CT), fluoroscopy and ultrasound, which provide critical benefits, such as direct real time imaging and improved success rate by a large margin. Advancements in materials, such as the substitution of stainless steel by cobalt chromium, which is 24% harder, helps to maintain tip sharpness and is more resilient to deformation over multiple passes, will further add to the growth of the pulmonary needles market. Innovations in design represent the largest market opportunity as market position is of critical importance in the industry. Innovative designs, such as ergonomic rotating handle and slip resistant grip, for better needle control and precision, are gaining a large traction.

The restraints in the pulmonary needles market are the various risks, such as chest pain, nosocomial infection, difficulty in breathing, fever or swelling and bleeding from the site.

Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=1171

Pulmonary Needles Market: Segmentation

To gain a bird’s eye view and a better understanding of the future market equity, the pulmonary needles report is segmented based on clinical indication, loading mechanism, end user and region.

Based on clinical indications, the global pulmonary needles market is divided into the following:

Tumor
Malignancy
Non-Malignant
Infectious Diseases
Cardiovascular
Inflammation
Others
Based on loading mechanism, the global pulmonary needles market is divided into the following:

Manual
Spring loading
Others
Based on end user, the global pulmonary needles market is segmented as below:

Hospitals
Ambulatory Surgical Centers
Others
Pulmonary Needles Market: Overview

The global market for pulmonary needles is consolidated with a few large players dominating the scene. The market trends include combined approaches of using pulmonary needles with acoustic imaging to obtain accurate diagnosis and prognosis of conditions, which is expected to create high market demand. Some of the established brands of pulmonary needles are Veran Medical Technologies, Cook Medical, Veran Medical Technologies, Bostonscientific, argonmedical, BreStem Therapeutics, SOMATEX Medical Technologies GmbH, Medi-Globe GmbH and others.

Pulmonary needles Market: Regional Wise Outlook

The global pulmonary needles market is classified into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan and Middle East and Africa. North America is expected to account for the largest share in the global pulmonary needles market owing to the high concentration of key market players, excellent reimbursement rate and large healthcare expenditure amounting to 16% of GDP in 2016. The approval of Medicare & Medicaid Services (CMS) for Screening of Lung Cancer is expected to further drive large market adoption.

The Asia Pacific market excluding Japan is expected to grow at a significant CAGR owing to the expansion of healthcare and growing prosperity in the country. China and India are expected to hold the lion’s share in the market. Europe, led by Germany, France and the UK, is expected to make the second largest market. The Middle East and Africa pulmonary needles market is expected to incline towards gulf economies, such as Saudi Arabia, Kuwait and Qatar.

Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=1171

Pulmonary needles Market: Key Players

Some of the major players in the global pulmonary needles market are Veran Medical Technologies, Cook Medical, Veran Medical Technologies, Boston scientific, argonmedical, BreStem Therapeutics, SOMATEX Medical Technologies GmbH, Medi-Globe GmbH and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

Report Analysis@ https://www.factmr.com/report/1171/pulmonary-npulmonary-needles-market

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Needles Market Projected to Augment at a Notable CAGR during the Forecast Period until 2028(Based on clinical indications, the global pulmonary needles market is divided into the following: Tumor Malignancy Non-Malignant Infectious Diseases Card here

News-ID: 1743161 • Views: 111

More Releases from Fact.MR

11-09-2020 | Health & Medicine
Fact.MR
PCR and Real-time PCR Molecular Diagnostics Market to Surpass US$ 6 Bn by 2030, …
As per data from the World Health Organization, millions of deaths can be attributed to diseases such as cancer and HIV each year. Further, the recent outbreak of the COVID-19 virus has also created massive demand for effective diagnostics processes. The PCR and real-time PCR molecular diagnostics market has been gaining traction in recent years on the back of investments by PCR diagnostic test manufacturers towards the incorporation of molecular
10-05-2020 | Health & Medicine
Fact.MR
Biobanking Market to Soar to US$ 3.5 Bn by 2027, Notes Fact.MR
Biobanks are a type of repository which is used in the storage of biological samples, including human and animal tissues, which primarily find use in research applications. Consequently, the process of biobanking has become a very important part of medical research and has played a major role in modern science fields such as personalized medications, and genomics. The global biobanking market is expected to grow at a healthy CAGR of ~
Mini LED Market to Expand 7.5X by 2030, Finds New Study by Fact.MR
In recent years, increasing popularity of OLED TVs in China and India has been significantly influencing growth of the mini LED market. With an increase in disposable income of a majority of the population in these countries, the inclination towards smart screens with higher lifespan and better performance is expected to open up numerous growth opportunities for the mini LED market. Moreover, aspiring and affluent households have increased their spending
Uncertainty Surrounding COVID-19 to Shave-off Growth in Electrical Steel Market …
The global electrical steel market has utilized the opportunities in the market over the last decade with sales of electrical steel pegged at US$ 20.4 Bn in 2019. However, sales are set to plummet during in the middle two quarters of 2020 owing to COVID-19. In addition, several automakers have shuttered their production units, causing incalculable loss to the electrical steel market in 2020. However, the demand of electrical steel

All 5 Releases


More Releases for Pulmonary

Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
Global Pulmonary Arterial Hypertension Market to 2024
Global Pulmonary Arterial Hypertension (PAH) market was valued at $5.0bn in 2015 and is forecast to grow at a modest 6.0% CAGR between 2015 and 2024, to result in 2024 global sales of $9.0bn. PAH is broadly split into two classes, primary or secondary. Primary pulmonary hypertension (PPH) refers to pulmonary hypertension occurring without an identifiable cause. Secondary pulmonary arterial hypertension (PAH) occurs in association with some other identifiable medical condition.
Pulmonary Fibrosis Market Professional Survey Report 2017
Global Pulmonary Fibrosis Market: Snapshot Pulmonary fibrosis belongs to the family of interstitial diseases that can lead to damage of the lungs. As the lung tissue becomes stiff and thickened, it interferes with a person’s ability to breathe. The scarring of lung tissues is associated with a multitude of factors. However, in most cases, the cause of the problem can’t be determined. This state is termed as idiopathic pulmonary fibrosis. While the
Pulmonary Drugs 2024 Market Research Report
Global Pulmonary Drugs Market: Snapshot The global pulmonary drugs market has been the key area of focus and the most crucial market for the healthcare industry in the last couple of years. However, the market is expected to witness a significant decline over the forecast period with a -6.3% CAGR from 2016 to 2024. The market is anticipated to fall to US$28,082.1 mn from a valuation of US$48,039.7 mn in
Latest Report: Global Pulmonary Hypertension Market
MarketResearchReports.Biz presents this most up-to-date research on "Pulmonary Hypertension-Pipeline Insights, 2017" DelveInsights, Pulmonary Hypertension-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Pulmonary Hypertension. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations,